Heart Failure After ST-Elevation Myocardial Infarction: Beyond Left Ventricular Adverse Remodeling

Area of Science:

• Cardiology
• Cardiovascular Research
• Internal Medicine

Background:

• ST-segment elevation myocardial infarction (STEMI) is a major global health concern.
• Advances in STEMI treatment reduce early mortality but heart failure (HF) risk persists.
• Traditional HF post-STEMI involves left ventricular adverse remodeling (LVAR) leading to reduced ejection fraction (HFrEF).

Purpose of the Study:

• To investigate the evolving patterns of heart failure following STEMI.
• To identify new paradigms of HF in STEMI survivors.
• To understand the mechanisms of HF independent of LVAR.

Main Methods:

• Review of STEMI treatment outcomes and HF development.
• Analysis of patient cohorts to identify HF phenotypes post-STEMI.
• Characterization of HF with preserved ejection fraction (HFpEF) in STEMI survivors.

Main Results:

• While LVAR and HFrEF are reduced, HF risk remains substantial.
• A new paradigm of HFpEF is emerging in STEMI survivors.
• HFpEF in this context is characterized by diastolic or systolic reserve reduction, independent of LVAR.

Conclusions:

• STEMI treatment advancements have altered HF development patterns.
• HFpEF represents a significant and growing concern in STEMI survivors.
• Further research is needed to understand and manage HFpEF post-STEMI.